Coronavirus
WHO gives emergency approval to Sinopharm, first Chinese COVID-19 vaccine
The World Health Organization announced on Friday it had approved a COVID-19 vaccine from China’s state-owned drugmaker Sinopharm for emergency use.
The vaccine, one of two main Chinese shots that collectively have already been given to hundreds of millions of people in China and abroad, becomes the first COVID-19 shot developed by a non-Western country to win the WHO’s backing.
For more coronavirus news, visit our dedicated page.
It is also the first time the WHO has given emergency use approval to any Chinese vaccine for any infectious disease.
A WHO emergency listing is a signal to national regulators on a product’s safety and efficacy, and would allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries.
The WHO has previously given emergency approval to COVID-19 vaccines developed by Pfizer-BioNTech, AstraZeneca, Johnson & Johnson, and, last week, Moderna.
Read more: UAE firm to start producing China’s Sinopharm COVID-19 vaccine after deal
Also Read
-
WHO experts voice “very low confidence” in some Sinopharm COVID-19 vaccine data
WHO experts have voiced “very low confidence” in data provided by Chinese state-owned drugmaker Sinopharm on its COVID-19 vaccine regarding the risk ... Coronavirus -
Indonesia approves China’s Sinopharm COVID-19 vaccine for emergency use
Indonesia’s drug regulator on Friday approved the COVID-19 vaccine of China’s Sinopharm, which it will use in a private immunization scheme where ... Coronavirus
